New York Workers' Compensation Board says NO to Medicare hold harmless language in Section 32 Waiver Agreements
2 MIN READ
On March 2, 2020, the New York State Workers’ Compensation Board (Board) published Subject No. 046-372 which announced that the Board determined that it will no longer approve Section 32 waiver agreements that require a claimant to indemnify and/or hold the carrier harmless.
Medicare Secondary Payer Updates
2 MIN READ
Miscellaneous Medicare Secondary Payer Clarifications and a Reminder for Non-Group Health Plan (NGHP) Responsible Reporting Entities (RREs) Regarding Medicare Beneficiary Identifier (MBI) Reporting
StateWatch: Bill Review August 2019
3 MIN READ
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Bill Review July 2019
4 MIN READ
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Bill Review May/June 2019
2 MIN READ
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Bill Review April 2019
3 MIN READ
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Spring 2019
10 MIN READ
Kaiser Health News reported that doctors in a growing number of states are now required to offer a prescription for overdose antidote naloxone at the same time opioids are prescribed under certain circumstances, a development that could add to the growth in naloxone prescriptions in workers’ comp.